Eid RA, Bin-Meferij MM, El-Kott AF, et al
La sua patogenesi non del tutto nota, ma ricondotta a unalterata perfusione della porzione retrolaminare del nervo ottico
Adicionalmente, el ensayo SELECT (2023), publicado en NEJM, demostr que semaglutida 2.4 mg redujo el riesgo de eventos cardiovasculares mayores (infarto, ictus, muerte cardiovascular) en un 20% en adultos con sobrepeso u obesidad y enfermedad cardiovascular establecida, pero sin diabetes
These results position Epitalon as a potential candidate for stabilizing cholinergic tone, a critical early disruption in age-related cognitive decline, and for addressing cognitive disorders associated with cholinergic deficiency and amyloid metabolism